TGFB1 and prostate carcinoma: The aim of the present study was to examine the possible associations between individual and clinical parameters, as well as circulating levels of IL-6 and TGF-β1, and the occurrence of main adverse effects of radiotherapy in patients with prostate cancer – acute and late GU and GI radiotoxicity, as well as fatigue intensity.